Fidson, Led By Fidelis Ayebae, Declares 1.49 Million Dividend For Shareholders

Fidson Healthcare boosts its final dividend by 66.67, rewarding shareholders after a strong 2024 financial performance.

The companys profit surged 40 to N5.05 billion 3.41 million, fueled by rising demand for ethical and OTC drugs.

Fidelis Ayebae leads a 100 million expansion, reinforcing Fidsons position as a key player in Nigerias pharmaceutical sector.

Fidson Healthcare Plc, a prominent Lagos-based pharmaceutical manufacturer founded by Nigerian mogul Fidelis Ayebae, is set to reward its shareholders with a final dividend payout of 1.49 million for the 2024 fiscal year.

The payout reflects the pharmaceutical groups focus on rewarding investors following an impressive financial performance in 2024, driven by higher demand for ethical products, including infusions, capsules, and tablets.

The company increased its final dividend by 66.67 percent , bringing it to N1 0.0007 per share. This amounts to a total payout of N2.29 billion 1.49 million, compared to N1.38 billion 0.9 million the previous year, when the dividend stood at N0.60 per share.

The dividend is still subject to shareholder approval at the upcoming AGM and will be paid from the profits earned in the year ending Dec. 31, 2024.

Fidson posted impressive results for 2024 , with a nearly 40 percent increase in profitfrom N3.61 billion 2.44 million in 2023 to N5.05 billion 3.41 million.